BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7085073)

  • 1. Chemotaxis of purified human monocytes in vitro: lack of accessory cell requirement.
    Falk W; Leonard EJ
    Infect Immun; 1982 May; 36(2):591-7. PubMed ID: 7085073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of human monocyte chemoattractant binding by flow cytometry.
    Leonard EJ; Noer K; Skeel A
    J Leukoc Biol; 1985 Sep; 38(3):403-13. PubMed ID: 3861752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Only the chemotactic subpopulation of human blood monocytes expresses receptors for the chemotactic peptide N-formylmethionyl-leucyl-phenylalanine.
    Falk W; Harvath L; Leonard EJ
    Infect Immun; 1982 May; 36(2):450-4. PubMed ID: 6282748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two neutrophil populations in human blood with different chemotactic activities: separation and chemoattractant binding.
    Harvath L; Leonard EJ
    Infect Immun; 1982 May; 36(2):443-9. PubMed ID: 7085067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid method for monocyte isolation and chemotaxis.
    Antrum RM; Solomkin JS
    J Clin Lab Immunol; 1986 Mar; 19(3):139-42. PubMed ID: 3712418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity and reversibility of chemotactic deactivation of human monocytes.
    Falk W; Leonard EJ
    Infect Immun; 1981 May; 32(2):464-8. PubMed ID: 6265358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis.
    Smith PD; Ohura K; Masur H; Lane HC; Fauci AS; Wahl SM
    J Clin Invest; 1984 Dec; 74(6):2121-8. PubMed ID: 6511917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monocyte adherence: a primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium.
    Doherty DE; Haslett C; Tonnesen MG; Henson PM
    J Immunol; 1987 Mar; 138(6):1762-71. PubMed ID: 3819394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte chemotaxis: a method for routine in vitro investigation using lactic dehydrogenase as a marker enzyme.
    Mrowietz U; Ternowitz T
    Acta Pathol Microbiol Immunol Scand C; 1987 Feb; 95(1):1-7. PubMed ID: 3577766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of density changes and chemotactic receptors of leukocytes from chronic hemodialysis and peritoneal dialysis patients.
    Lewis SL; Van Epps DE; Chenoweth DE
    Blood Purif; 1987; 5(2-3):138-54. PubMed ID: 3040039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic nucleotides regulate the morphologic alterations required for chemotaxis in monocytes.
    Stephens CG; Snyderman R
    J Immunol; 1982 Mar; 128(3):1192-7. PubMed ID: 6120193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monocyte chemotaxis to complement-derived chemotaxins is enhanced by Gc-globulin.
    Piquette CA; Robinson-Hill R; Webster RO
    J Leukoc Biol; 1994 Mar; 55(3):349-54. PubMed ID: 8120452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of monocyte function by complement activation products.
    Antrum RM; Solomkin JS
    J Surg Res; 1985 May; 38(5):468-74. PubMed ID: 3990275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human monocyte chemotaxis in vitro. Influence of in vitro variables in the filter assay.
    Nielsen H; Olesen Larsen S
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):109-15. PubMed ID: 6349251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of monocyte chemotaxis to C-C chemokines by antisense oligonucleotide for cytosolic phospholipase A2.
    Locati M; Lamorte G; Luini W; Introna M; Bernasconi S; Mantovani A; Sozzani S
    J Biol Chem; 1996 Mar; 271(11):6010-6. PubMed ID: 8626384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotaxin receptors on human neutrophils: modulation of C5a and peptide receptor number.
    Nelson RD; Chenoweth DE; Solomkin JS; Solem LD
    Agents Actions Suppl; 1983; 12():274-89. PubMed ID: 6301231
    [No Abstract]   [Full Text] [Related]  

  • 17. Methyl ester of N-formylmethionyl-leucyl-phenylalanine: chemotactic responses of human blood monocytes and inhibition of gold compounds.
    Ho PP; Young AL; Southard GL
    Arthritis Rheum; 1978; 21(1):133-6. PubMed ID: 414757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of monocyte responses to chemotaxins are associated with human neoplasms.
    Snyderman R; Cianciolo G
    Adv Exp Med Biol; 1982; 155():343-52. PubMed ID: 7158488
    [No Abstract]   [Full Text] [Related]  

  • 19. Density changes in leukocytes following hemodialysis or exposure to chemotactic factors.
    Lewis SL; Van Epps DE; Chenoweth DE
    Am J Nephrol; 1986; 6(1):34-41. PubMed ID: 3963057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment.
    Clark RA; Wikner NE; Doherty DE; Norris DA
    J Biol Chem; 1988 Aug; 263(24):12115-23. PubMed ID: 3403561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.